Zhejiang Hisun Pharmaceutical Co., Ltd. (600267.SS) SHH

Currency In CNY

AD

Valuation

Market Cap11.63B
Enterprise Value12.52B
P/E Ratio18.65
PEG Ratio0.63
Price/Sales Ratio1.3
Price/Book Ratio1.45
Enterprise/Revenue1.26
Enterprise/EBITDA7.62

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.07
Operating Margin0.09
AD

Management Effectiveness

Return On Assets0.05
Return On Equity0.08

Income Statement

Revenue10.55B
Revenue/Share8.98
Gross Profit4.73B
EBITDA1.89B
Net Income540.71M
Diluted EPS0.46

Balance Sheet

Total Cash1.86B
Total Cash/Share1.62
Total Debt1.44B
Total Debt/Equity0.16
Current Ratio1
Book Value Per Share8.01

Price History

52-Week Change-7.28
52-Week High12.98
52-Week Low9.35
Moving Average 50 Days10.49
Moving Average 200 Days10.53

Statistics

Average Volume24.84M
Shares Outstanding1.18B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.21
Trailing Annual Dividend Yield1.85
Payout Ratio0.44
Last Split Factor8:5
Last Split DateMay 25, 2012
AD